These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. [Immunoglobulins and immune deficiency: methods of administration]. Suarez F Rev Med Interne; 2005 Oct; 26 Spec No 1():25-8. PubMed ID: 16475260 [No Abstract] [Full Text] [Related]
67. Multiorgan failure induced by intravenous immunoglobulin. Ikeda M; Hamasaki Y; Hataya H; Honda M; Sugai K Acta Paediatr; 2000 Nov; 89(11):1393. PubMed ID: 11106058 [No Abstract] [Full Text] [Related]
68. Complications of intravenous immune globulin treatment in neurologic disease. Achiron A Neurology; 1997 Sep; 49(3):899-900. PubMed ID: 9305372 [No Abstract] [Full Text] [Related]
69. Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications. Rocchio MA; Hussey AP; Southard RA; Szumita PM Am J Health Syst Pharm; 2013 May; 70(9):751-2. PubMed ID: 23592355 [No Abstract] [Full Text] [Related]
70. Administration of intravenous immunoglobulin to a patient with hypogammaglobulinemia and anti-IgA antibodies. Lieberman P; Rachid R J Allergy Clin Immunol Pract; 2013; 1(6):704. PubMed ID: 24565726 [No Abstract] [Full Text] [Related]
71. High-dose intravenous immune globulin for stiff-person syndrome. Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577 [TBL] [Abstract][Full Text] [Related]
72. Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go? Scott DE; Epstein JS Transfusion; 2015 Jul; 55 Suppl 2():S122-6. PubMed ID: 26174890 [No Abstract] [Full Text] [Related]
73. Polyvalent immune globulin usage by indication in the United States, 2012: a quantitative analysis of the use of polyvalent immune globulin (intravenous and subcutaneous) by medical indication in the United States in 2012. Robert P; Hotchko M Transfusion; 2015 Jul; 55 Suppl 2():S6-12. PubMed ID: 26174899 [No Abstract] [Full Text] [Related]
75. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation. Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279 [TBL] [Abstract][Full Text] [Related]